LXRX - Lexicon Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts5577
Avg. Estimate-0.080.03-0.26-0.56
Low Estimate-0.16-0.22-0.78-1.23
High Estimate0.050.340.310.05
Year Ago EPS-0.33-0.26-1.14-0.26
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts4466
Avg. Estimate28.52M31.77M107.11M96.77M
Low Estimate16.96M13.7M59.31M40M
High Estimate40.2M51M175M154M
Year Ago Sales13.75MN/A63.21M107.11M
Sales Growth (year/est)107.40%N/A69.50%-9.70%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.34-0.33-0.29-0.22
EPS Actual-0.33-0.26-0.16-0.21
Difference0.010.070.130.01
Surprise %2.90%21.20%44.80%4.50%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.080.03-0.26-0.56
7 Days Ago-0.080.03-0.26-0.56
30 Days Ago-0.080.03-0.26-0.56
60 Days Ago-0.160.07-0.36-0.65
90 Days Ago-0.210.17-0.24-0.41
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days4353
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesLXRXIndustrySectorS&P 500
Current Qtr.75.80%N/AN/A0.02
Next Qtr.111.50%N/AN/A0.04
Current Year77.20%N/AN/A0.05
Next Year-115.40%N/AN/A0.10
Next 5 Years (per annum)54.70%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A